Cytokinetics Inc (CYTK)
Pretax margin
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | -526,244 | -526,728 | -539,616 | -430,799 | -388,955 | -282,145 | -215,921 | -257,655 | -215,314 | -228,674 | -155,763 | -134,989 | -127,290 | -114,000 | -140,398 | -131,731 | -121,692 | -117,520 | -109,964 | -105,374 |
| Revenue (ttm) | US$ in thousands | 7,530 | 7,815 | 9,952 | 95,246 | 91,781 | 141,206 | 139,967 | 56,649 | 58,061 | 9,383 | 45,819 | 46,569 | 47,834 | 47,611 | 14,609 | 16,776 | 20,245 | 23,344 | 29,275 | 29,730 |
| Pretax margin | -6,988.63% | -6,739.96% | -5,422.19% | -452.30% | -423.79% | -199.81% | -154.27% | -454.83% | -370.84% | -2,437.11% | -339.95% | -289.87% | -266.11% | -239.44% | -961.04% | -785.23% | -601.10% | -503.43% | -375.62% | -354.44% |
December 31, 2023 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $-526,244K ÷ $7,530K
= -6,988.63%
The pretax margin of Cytokinetics Inc has fluctuated significantly over the past eight quarters, with negative values observed in all periods. The highest observed pretax margin was -142.85% in Q2 2022, while the lowest was recorded at -6,988.63% in Q4 2023. This indicates that the company's expenses and costs have consistently exceeded its revenues before accounting for taxes, resulting in substantial losses. The downward trend in pretax margin suggests that Cytokinetics Inc may be facing challenges in controlling costs and generating sufficient income to cover its operating expenses. Further analysis of the company's operations and financial health would be necessary to understand the underlying reasons for these negative pretax margins and to identify potential areas for improvement.
Peer comparison
Dec 31, 2023